Expertise in
6
conditions

Guido Hildebrandt

Rostock, MV, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
6
conditions
Rostock, MV, DE 

Overview

Guido Hildebrandt practices practicing medicine in Rostock, Germany.

Mr. Hildebrandt is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Lung Metastases, Prostate Cancer, Breast Cancer, Mastectomy, and Prostatectomy.

He is actively involved in clinical research, co-authoring 148 peer reviewed articles and participating in 6 clinical trials.

Gender

Male

Locations

Rostock, MV, Germany
Other Locations
Universitätsmedizin Rostock, Rostock
Mecklenburg, MV, Germany
Leipzig, SN, Germany
Universitätsmedizin Greifswald
Greifswald, MV, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)
PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)
Enrollment Status: Recruiting
Publish Date: November 03, 2023
Intervention Type: Radiation
Study Phase: Not Applicable
Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma.
Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma.
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2024
Intervention Type: Radiation, Drug
Study Drugs: Durvalumab, 5-Fluorouracil, Mitomycin C
Study Phase: Phase 2
Perioperative Chemotherapy (FLOT Protocol) Compared To Neoadjuvant Chemoradiation (CROSS Protocol) in Patients With Adenocarcinoma of the Esophagus
Perioperative Chemotherapy (FLOT Protocol) Compared To Neoadjuvant Chemoradiation (CROSS Protocol) in Patients With Adenocarcinoma of the Esophagus
Enrollment Status: Active_not_recruiting
Publish Date: May 08, 2024
Intervention Type: Radiation, Drug
Study Drugs: 5-Fluorouracil, Leucovorin, Oxaliplatin, Docetaxel, Carboplatin, Paclitaxel
Study Phase: Phase 3
Hypofractionated Radiosurgery for Localised Prostate Cancer
Hypofractionated Radiosurgery for Localised Prostate Cancer
Enrollment Status: Completed
Publish Date: March 21, 2024
Intervention Type: Radiation
Study Phase: Not Applicable
SAKK 08/15 - PROMET - Multicenter, Randomized Phase II Trial of Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy
SAKK 08/15 - PROMET - Multicenter, Randomized Phase II Trial of Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy
Enrollment Status: Terminated
Publish Date: April 14, 2022
Intervention Type: Radiation, Drug
Study Drug: Metformin
Study Phase: Phase 2
Postoperative Radiotherapy of Non-small Cell Lung Cancer: Accelerated vs. Conventional Fractionation
Postoperative Radiotherapy of Non-small Cell Lung Cancer: Accelerated vs. Conventional Fractionation
Enrollment Status: Completed
Publish Date: July 22, 2020
Intervention Type: Radiation
Study Phase: Not Applicable
View 5 Less Clinical Trials

148 Total Publications

Axillary surgery in patients with sentinel node macrometastases: secondary results of the randomized INSEMA trial.
Axillary surgery in patients with sentinel node macrometastases: secondary results of the randomized INSEMA trial.
Journal: NPJ breast cancer
Published: December 04, 2025

Frequently Asked Questions about Guido Hildebrandt

Is Guido Hildebrandt a top-rated expert for Lung Metastases?

MediFind is an objective health platform that identifies experts based on real-world data. Guido Hildebrandt is classified as an Advanced expert for Lung Metastases, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Guido Hildebrandt participate in research or clinical trials?

Yes. Guido Hildebrandt has published 148 articles and abstracts on conditions like Lung Metastases. You can view a list of Guido Hildebrandt's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hildebrandt's expertise for a condition
ConditionClose
      View All 17 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile